How big is the Market for Statins | Size, Share & Growth Insights 2025

Q: What is the current size of the statins market?

It was valued at USD 15.8 Billion in 2024 and is expected to reach USD 21.4 Billion by 2031.

Q: What is the CAGR of the statins market?

The statins market is projected to grow at a CAGR of 4.40% from 2025 to 2031.

Q: What drives growth in the statins market?

Rising heart disease burden, strong clinical efficacy, and affordable generics drive growth.

Q: What are the main types of statins available?

Atorvastatin, rosuvastatin, simvastatin, pravastatin, and lovastatin.

Q: Which region leads the statins market?

North America leads due to high cardiovascular risk awareness and widespread drug use.

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Code: MTA7526

Publication Date: Aug 2025

How big is the statins market?

According to 6Wresearch internal database and industry insights, the Statins Market was valued at USD 15.8 Billion in 2024 and is expected to reach USD 21.4 Billion by 2031, growing at a compound annual growth rate of 4.40% during the forecast period of 2025 to 2031.

The growth is driven by the rising prevalence of cardiovascular diseases, increasing geriatric population, and expanded use of statins in both primary and secondary prevention of heart disease.

Key Growth Drivers of the Statins Market

Rising cases of hypercholesterolemia and cardio-vascular disorders
The extensive use of statins as first-line lipid-reduction treatment
Positive clinical guidelines and prescription rates among aging populations
Enhancing preventive health behaviour and health enlightenment
Accessibility of generic statins enhancing affordability and accessibility

Statins Market Trends

Statins market is witnessing trends such as a shift toward combination therapies with other lipid-lowering agents like ezetimibe and PCSK9 inhibitors. There is growing focus on adherence-improving fixed-dose combinations. Real-world data and long-term outcomes are influencing prescribing behaviour. Increasing use of telemedicine and online pharmacies is supporting statin accessibility. Demand for personalized treatment based on genetic profiling is also emerging.

Emerging Developments in the Statins Market

Statins market has emerging developments including research into statin pleiotropic effects beyond lipid reduction, such as anti-inflammatory benefits. New delivery mechanisms are under study to reduce side effects and enhance efficacy. Digital pill tracking and remote patient monitoring solutions are being explored. Companies are also investing in expanding statin use in underserved regions with high cardiovascular risk. Biosimilar statins and fixed-dose innovations are accelerating approvals globally.

List of Leading Companies in the Statins Market

Below is a comprehensive list of the leading market players driving growth in this sector:

1. Pfizer Inc.

Company Name	Pfizer Inc.
Established Year	1849
Headquarters	New York, USA
Official Website	Click Here

Pfizer is a leading manufacturer of atorvastatin (Lipitor), one of the most widely prescribed statins globally, used for managing cholesterol and heart risk.

2. Merck & Co., Inc.

Company Name	Merck & Co., Inc.
Established Year	1891
Headquarters	New Jersey, USA
Official Website	Click Here

Merck developed simvastatin (Zocor) and continues to offer a portfolio of cardiovascular drugs, maintaining a strong presence in lipid-lowering therapies.

3. AstraZeneca plc

Company Name	AstraZeneca plc
Established Year	1999
Headquarters	Cambridge, UK
Official Website	*Click Here*

AstraZeneca manufactures rosuvastatin (Crestor), a high-potency statin that has played a significant role in cholesterol control and cardiovascular prevention.

4. Novartis AG

Company Name	Novartis AG
Established Year	1996
Headquarters	Basel, Switzerland
Official Website	Click Here

Novartis offers branded and generic statin therapies and focuses on combining lipid-lowering drugs with novel cardiovascular treatments for better outcomes.

5. Sun Pharmaceutical Industries Ltd.

Company Name	Sun Pharmaceutical Industries Ltd.
Established Year	1983
Headquarters	Mumbai, India
Official Website	Click Here

Sun Pharma is one of the largest global suppliers of generic statins, exporting high-volume formulations like atorvastatin and rosuvastatin to key markets.

6. Teva Pharmaceutical Industries Ltd.

Company Name	Teva Pharmaceutical Industries Ltd.
Established Year	1901
Headquarters	Tel Aviv, Israel
Official Website	Click Here

Teva is a major player in the generic statins space, offering multiple dosage forms globally as part of its expansive cardiovascular product portfolio.

7. Mylan N.V. (now part of Viatris)

Company Name	Mylan N.V. (now part of Viatris)
Established Year	2020 (Merger Year)
Headquarters	Pennsylvania, USA
Official Website	*Click Here*

Mylan, now Viatris, provides cost-effective generic statins across global markets, supporting large-scale access to cholesterol-lowering therapies.

8. Dr. Reddy’s Laboratories Ltd.

Company Name	Dr. Reddy’s Laboratories Ltd.
Established Year	1984
Headquarters	Hyderabad, India
Official Website	*Click Here*

Dr. Reddy’s manufactures generic statins with global regulatory approvals, serving markets like the US and Europe with a strong cardiovascular product line.

9. Cipla Ltd.

Company Name	Cipla Ltd.
Established Year	1935
Headquarters	Mumbai, India
Official Website	Click Here

Cipla is a key producer of statins, offering affordable generic versions for domestic and international markets focused on preventive cardiac care.

10. Abbott Laboratories

Company Name	Abbott Laboratories
Established Year	1888
Headquarters	Illinois, USA
Official Website	*Click Here*

Abbott develops and markets statins and combination therapies in cardiovascular care, particularly in emerging markets with branded generics and diagnostics.